To probe the limits of CD8+ T cell immunosurveillance, we inserted the model peptide 34
Introduction

62
Influenza virus (IAV) causes significant worldwide morbidity and mortality due to its 63 efficient evasion of humoral immune responses. IAV elicits a robust CD8+ T cell 64 response, and extensive evidence in man and animals supports a role for CD8+ T cells 65
in limiting viral replication and reducing morbidity and mortality in hosts whose antibody 66 responses fail to prevent infection (1-4) . 67 68 CD8+ T cell immunosurveillance encompasses oligopeptides encoded by each of the 69 eight IAV gene segments. The exact peptides recognized by any infected individual is 70 governed largely by their classical MHC class I genes (HLA-A,-B,-C in humans, H-2 K, D, 71 L in mice) (5). In most species, each class I locus has thousands of alleles whose peptide 72 specificity varies based on polymorphisms in and around the peptide binding groove. 73 74
Following viral infection, viral peptide ligands are generated extremely rapidly, with rates 75 that parallel the translation of their source gene products (6) (7) (8) . As viral proteins typically 76 exhibit half-lives on the order of tens of h, the kinetic connection of peptide generation 77 with protein synthesis, not degradation, strongly implies that viral peptides derive from a 78 distinct pool of nascent gene products, termed DRiPs, for defective ribosomal products 79 (9). 80 81
Though the biochemical nature of DRiPs generated from wild-type proteins remains 82 largely undefined, viral peptides can clearly originate from non-canonical translation 83 products (10). This includes downstream initiation on AUG codons (11), read through of 84 stop codons (12, 13) , frame shifting (14, 15) , initiation on CUG or other alternative start 85 codons (16), stop codon read through (12, 17) and translation of viral RNA in the nucleus 86
(18). Inasmuch as each of these mechanisms would likely generate a defective gene 87 product that is rapidly degraded, they provide a clear source of immunologically relevant 88
DRiPs. 89 90
Negative strand viruses provide an intriguing opportunity for additional non-canonical 91 translation in immunosurveillance, as the negative strand provides a potential source of 92 peptides. Influenza viruses are of special interest since RNA transcription occurs in the 93 nucleus, which may increase the possibility of non-canonical translation (18-21), or 94 insertion of negative coding information into mRNA by RNA splicing, intended or 95
otherwise. Adding to the interest, a large open reading frame (ORF) encoding 167 or 96 more residues (depending on the viral strain) is present in the genomic strand of segment 97 8 ( Fig. 1A) , that has been conserved in human IAV isolates for the last 100 years (22, 98 23). MHC peptide prediction algorithms have identified several NEG8-derived peptides 99
capable of eliciting T cell responses after IAV infection, and one peptide is reported to be 100 immunogenic in IAV infected-mice (24). By contrast, evidence suggests that NEG8 is not 101 under positive selection in nature among IAV isolates (25). 102 103
Here we explore immunosurveillance of viral negative strand-encoded peptide by 104
inserting the model peptide SIINFEKL into several locations in genomic "non-coding" RNA 105 in IAV, including NEG8. SIINFEKL is a highly immunogenic peptide presented by H-2 K b 106 to CD8+ T cells (26), and its expression in vitro and in vivo can be monitored at high 107 sensitivity using OT-I transgenic T cells (27 We initially explored IAV negative strand translation by attempting to demonstrate NEG8 118 translation, which has not been verified experimentally in the context of an IAV infection. 119
We infected MDCK or HeLa cells with A/PR/8/34 (PR8) and used polyclonal rabbit 120 antibodies raised to synthetic peptides corresponding to the predicted NH2-or COOH-121 termini in immunoblots of whole cell lysates or in immunofluorescence of fixed and 122 permeabilized cells. Although rabbit sera demonstrated high titers against the 123 immunizing peptides in ELISA, they failed to specifically stain PR8-infected cells in 124
immunofluorescence, or to give a specific signal in immunoblots of total infected-cell 125
lysates. We also failed to detect NEG8 in similar experiments using antibodies to epitope 126 tags (His, Myc, Myc repeated 3X to increase anti-Myc Ab binding) that we had genetically 127 appended to the predicted COOH-terminus of NEG8 in a PR8 recombinant virus.
129
By contrast, we could easily detect NEG8 with COOH-terminal GFP expressed from 130 either a plasmid or a recombinant vaccinia virus (rVACV), consistent with a previous 131 report that the protein is stably expressed by a recombinant baculovrius (28). As 132 predicted (29), rVACV-expressed NEG8-GFP is present in the ER and post-ER 133 compartments (Supplemental Figure 1) , as shown by clear localization to the nuclear 134 membrane and co-localization of GFP signal with Abs specific for ER (PDI) and trans-135
Golgi complex (TGN46 33-40, binds to K b and activates IAV-induced CD8+ T cells in vitro (24). We were unable 151 to confirm that NEG833-40 binds K b by a standard flow-based K b stabilization assay 152 (Supplemental Figure 2) . 153 154
To further examine potential immunosurveillance of IAV genomic RNA we generated 155 NEG8SIIN, a PR8-recombinant virus with SIINFEKL fused to the putative NEG8 COOH-156 terminus ( Fig. 1B) . SIINFEKL forms a highly stable complex with the mouse K b class I 157 molecule that can be detected by either the 25D-1.16 mAb, or at highest sensitivity, by 158
OT-I transgenic T cells. 159 160
Inserting sequences into genomic RNA will, of course, alter proteins encoded by the 161 positive-sense strand. Although PR8 NEG8SIIN has an 8-residue insertion between 162
resides 89 and 90 of NS1, the virus replicates in embryonated chicken eggs at levels 163 similar to wild-type (wt) virus. Sequencing of egg-grown stocks confirmed the presence 164 of the SIINFEKL-encoding insert, demonstrating that NS1 can function with an essentially 165 random insertion of eight amino acids after residue 89. Though the function of NS1 with 166 an 8-residue insertion might seem surprising, it is likely explained by the perhaps not 167
completely fortuitous location (see Discussion) of the insertion in the extended 168 polypeptide that links the NS1 effector and RNA binding domains (Supplemental Figure  169 3). Following infection of DC2.4 cells (a B6-mouse derived, dendritic cell-like cell line 170
(30)) with NEG8SIIN or wt PR8, flow cytometry revealed similar expression kinetics of NS1 171 using fixed and permeabilized cells and HA-or NA-staining prior to fixation ( Fig. 1D) .
173
We next incubated NEG8-SIIN-or PR8-infected DC2.4 cells with OT-I CD8+ T cells, and 174 measured T cell activation after 1 d by induction of the CD69 or CD25 activation markers 175 or by cell division (measured by dilution of CFSE label) ( Fig. 2) . Two positive controls, 176
SIINFEKL peptide-supplemented cultures and cells infected with PR8 with SIINFEKL 177 inserted into the NA stalk (PR8 NASIIN) (31, 32), confirmed that DC2.4 expressing K b -178 SIINFEKL can robustly activate OT-I cells under these conditions. By contrast, uninfected 179 cells or cells infected with PR8 lacking SIINFEKL failed to express activation markers or 180
to divide, demonstrating the expected requirement for DC2.4 cell presentation of K b -181 SIINFEKL complexes. Remarkably, NEG8SIIN-infected cells activated OT-I cells at similar 182 or even higher levels relative to the positive controls, as assessed by activation markers 183 or cell division. To our knowledge, this provides the first direct evidence of translation of 184 genetic information from the IAV negative strand. 185 186
Generating additional recombinant PR8 viruses ( Fig. 3) , revealed that a start codon at 187 the predicted NH2-terminus of NEG8SIIN is not required for generation of SIINFEKL from 188 infected DC2.4 cells, as determined by in vitro induction of CD69 on OT-I T cells using a 189 virus in which the initiating Met is replaced by Thr (Met(-)NEG8SIIN). Further, a stop codon 190
immediately upstream of SIINFEKL (StopNEG8SIIN) abrogates K b -SIINFEKL generation, 191
though not completely, consistent with read-through translation. Note that flow cytometric 192 detection of NA on live cell surfaces confirmed that cells were well infected by the various 193
PR8 viruses used (all over 90% positive).
195
These findings indicate that initiation can occur downstream of the first AUG in the NEG8 196
ORF. ATGpr bioinformatic software (http://atgpr.dbcls.jp/) predicts that initiation is nearly 197 equally likely to occur on the second of the 6 NEG8 AUG codons (reliability score of 0.14 198 vs. 0.12 for first vs. second AUG), which would encode a 93-residue polypeptide. 199
Initiation could also occur on any of other 4 AUG codons, despite their low score (all at 200 background levels), since the accuracy of the algorithm falls off at the bottom end, with a 201 specificity of only 20%. In addition, we note the presence of 4 CUG codons that could 202 support initiation, particularly since CUG initiation is likely favored during IAV infection 203 (16, 33) . 204 205
It important to mention that while PR8 NEG8SIIN-infected cells consistently activated OT-206 I CD8+ T cells, we only detected K b -SIINFEKL complexes on the cell surface using the 207 K b -SIINFEKL complex-specific 25-D1.16 mAb (34) in aminor fraction experiments; always 208 perilously close to the limits of detection. As OT-I cells are approximately 30-fold more 209 sensitive than 25-D1.16-based detection (34), this is consistent with the generation of low 210
NEG8SIIN is Sufficiently Translated in vivo to Enable Immunosurveillance 213 214
To establish the in vivo relevance of these findings, we transferred 2 x 10 5 CD45.1 + OT-I 215 CD8+ T cells into C57Bl/6 (CD45.2 + ) mice and infected them one day later via 216
intraperitoneal injection with the various recombinant PR8 viruses ( Fig. 4) . Seven d p.i., 217
we enumerated OT-I (CD45.1 + ) cells in spleens and peritoneal exudate cells (PECs) by 218 flow cytometry. In control PR8-infected mice, there were few (< 0.2%) OT-I T cells present 219
in the spleen or PECs. In contrast, PR8 NASIIN infection increased OT-I T cell percentages 220
in both the spleen and PECs (20.8 ± 1.6 and 31.9 ± 2.5 % or total cells, respectively). In 221 NEG8SIIN-infected mice, 2.8 ± 0.2% of splenocytes and 5.5 ± 1.2% of PECs were OT-I 222
cells, approximately 10-20 times greater than background. Notably, the total number of 223
CD45.1 + OT-I T cells recovered was far greater than the number adoptively transferred, 224
indicating OT-I proliferation in response to SIINFEKL rather than solely altered 225 recruitment ( Fig. 4 A, B , far right panels).
227
To confirm OT-I activation by NEG8SIIN we assayed splenic and PECs for IFN-γ synthesis 228
by stimulating ex vivo with SIINFEKL or an irrelevant peptide ( Fig. 4C, D) . A majority of 229
OT-I cells in either NASIIN-or NEG8SIIN-infected mice produced IFN-γ in response to re-230 stimulation with SIINFEKL but not an irrelevant peptide, indicative of Ag-experienced, 231
effector CD8 + T cells. 232 233
Taken together these data clearly demonstrate that NEG8SIIN activates CD8+ T cells in 234 vivo, establishing that translation from the IAV genomic strand can occur in vivo. 235 236
Immunosurveillance Extends to Peptides Inserted Elsewhere in Genomic RNA 237 238
To extend these findings, we inserted SIINFEKL-encoding nucleotides elsewhere in 239 genomic RNA. To minimize the perturbation to coding sequences, we BLASTED reverse 240 strand ORF amino acid sequences against SIINFEKL to find the most homologous 241
naturally encoded sequence and then changed the negative strand sequence to encode 242 SIINFEKL. Unfortunately, inserting SIINFEKL at a position equivalent to residue 154 in 243 HA (H3 numbering) or residue 809 of PA, which in each case changed only 4 residues, 244
was incompatible with recovering infectious viruses. 245 246
We were, however, able to generate a virus (NArevSIIN) encoding negative strand 247 SIINFEKL inserted in a position corresponding with residue 42 in the NA stalk 248 (Supplemental Fig. 4) . NA stalk length is naturally variable in nature, and NA is able to 249 accept SIINFEKL in the positive strand with little consequence (31, 32) . Indeed, NArevSIIN 250 grew to wt titers. SIINFEKL synthesis could potentially initiate at an AUG three codons 251 upstream and would be terminated by a stop codon after translating 5 additional residues. 252
The next potential start site is located dozens of codons upstream, and is unlikely to be 253 relevant, since there are 6 intervening stop codons. 254 255
Although we failed to detect OT-I T cell activation with NArevSIIN infected DC2.4 cells in 256 vitro (Fig. 2) , we observed weak but consistent OT-I T cell activation in vivo following i.p. 257
infection, as assessed either by splenic and PEC OT-I T cell proliferation or IFN- 258
production ex vivo (Fig. 4) .
260
Thus, even in the absence of any selective pressure for gene expression as might occur 261
with NEG8 SIINFEKL, there is sufficient translation from essentially a random sequence 262
in genomic IAV RNA to enable CD8+ T cell immunosurveillance in vivo. 263 264 265
Discussion
267
Despite lurking for decades in the published IAV segment 8 sequence (35, 36) in full view 268 of clever students of IAV, evidence supporting the translation of the NEG8 ORF in the 269 context of a bona fide influenza infection is lacking. Using multiple antibody-based 270 approaches to detect NEG8 (raising rabbit antibodies to predicted NH2-and COOH-271
terminal peptides, generating NEG8 fused genetically to antibody epitope tags (Myc, HA, 272 SIINFEKL itself using a SIINFEKL specific mAb (37)), we failed to detect NEG8 in PR8-273
infected HeLa or MDCK cells by immunofluorescence or immunoblotting using extracts 274 prepared by immersing cells in boiling SDS extraction buffer to maximize protein 275 solubilization. It is likely that if the protein is synthesized in these cells, it is only in minute 276
quantities.
278
Given the unusual nature of its "mRNA" it would not be surprising if NEG8 is only 279
expressed physiologically under special circumstances in vivo. Perhaps expression is 280
limited to a subset of the wide variety of cells types that can be infected by IAV, which 281 include epithelial, endothelial, and hematopoietic cells. It is clearly of interest in future 282 experiments to examine possible NEG8 translation in whole organ extracts and frozen 283 sections of lungs and immune tissues of infected animals. 284 285
Our findings show that ribosomes in cultured cells and in vivo can initiate downstream of 286 the first AUG on the NEG8 ORF and continue translating to the predicted COOH-terminus 287 and the appended model CD8+ T cell peptide SIINFEKL. Such translation, may however, 288
be exclusively related to immunosurveillance, in which case the translation products may 289 be truncated and degraded rapidly, with encoded peptides being rescued from typically 290 rapid destruction by binding to MHC class I, and potentially, class II molecules as well 291 The nuclear localization of IAV transcription may be key to negative strand translation. 307
We previously reported that upon drug blockade of NA mRNA export from the nucleus of 308 cells infected with NA-SIINFEKL PR8, NA protein expression is reduced to a far greater 309 extent than K b -SIINFEKL generation (18) In summary, we show that, through an unknown mechanism, immunosurveillance 317 extends to the negative strand of at least a subset of RNA viruses. If this is a general 318 phenomenon, it implies negative strand information can potentially double the peptides 319
presented for T immunosurveillance of viruses and cancer cells. If such T cells exert 320 sufficient anti-viral activity to limit transmission, they could select for escape mutants that 321 will contribute to viral evolution, and whose significance will not be apparent from standard 322 analysis of viral ORFs. 323 324
Material and Methods
326
Confocal Microscopy 327
Hela cells were cultured on Nunc Lab-Tek chambered coverglass (Thermo 328
Fisher Scientific, Waltham MA) for 24 h in normal growth media. Cells were infected with 329 rVV-NEG8-GFP for 12 hours, fixed with cold acetone and incubated with rabbit polyclonal 330
Abs specific for TGN46 (NB110-40769, Novus Biologicals, Littleton CO) and 331 mouse PDI (ab2792, Abcam, Cambridge MA) following by Alexa 594 conjugated anti-332 rabbit and Alexa 647 conjugated anti-mouse IgG antibodies (Jackson ImmunoResearch, 333
West Grove PA (53-6.7), CD69 (H1.2F3), and CD25 (PC61) (all from eBioscience) and analyzed for Cell 352
Trace Violet fluorescence to determine cell division on a BD LSRII flow cytometer (BD).
353
Results were analyzed using FlowJo (Tree Star).
355
In vivo activation of OT-I cells 356
Twelve to 24 h prior to infection, we transferred 2 × 10 5 CD45. were treated with ethidium monoazide (Invitrogen) before washing, incubating with Fc 365 block (antibody 2.4G2 produced in house), and staining with anti-CD8 (clone 53-6.7) and 366
anti-CD45.1 (clone A20; eBioscience). After staining, cells were washed and fixed at 367 room temperature for 15 min with 1% paraformaldehyde. Cells were incubated overnight 368 at 4°C with Alexa Fluor 647 anti-IFN-γ (clone XMG1.2, eBioscience) diluted in PBS 369 containing 0.5% saponin (EMD Biosciences). Cells were analyzed on a BD LSR II and 370 results analyzed using FlowJo. 371 372
Peptide Binding Assay 373
Peptide binding was determined as described (41). Briefly, highly purified synthetic 374
peptides were dissolved at 1 mM in DMSO and diluted in FBS-free DMEM to limit 375 proteolysis. RMA/S cells cultured overnight at 27°C, washed, were then incubated with 376 indicated concentrations of peptides for 2 h at room temperature, incubated in the 377 presence of 5 μg/ ml brefeldin A at 37°C for 2 h, and then washed and stained with anti-378
Kb antibody AF6-88.5. Secondary staining was conducted with Alexa Fluor 647-coupled 379
goat anti-mouse IgG(H+L) (Life Technologies Recombinant viruses were rescued using an eight plasmid system. One microgram of 409 each of the eight wild-type and mutant plasmids and two micrograms of pDZ-PR8-NP 410
were mixed in 186 l Optimem medium (Life Technologies). 16 l of Trans-It LT1 (Mirus 411
Bio, Madison WI) was added and mixed, followed by incubation at room temperature for 412 one hour. 800ul Optimem was added and the mixture pipetted onto an aspirated 6-well 413 well of cells plated the previous day at 0.6 x 106 293-T cells plus 0.2 x 10 6 MDCK cells in 414 DMEM with 7.5% fetal calf serum. Transfected cells were incubated overnight at 37°C. 415
The following morning, medium was replaced with 3 ml DMEM without serum containing 416 50 g/ml gentamycin (Quality Biological, Gaithersburg MD), 3 g/ml L-(tosylamido-2-417 phenyl) ethyl chloromethyl ketone (TPCK)-treated trypsin (Worthington Biochemical, 418 Lakewood NJ) and 25mM HEPES (Quality Biological). Over the following days, 419
supernatant media was removed and assayed for hemagglutinin activity. To grow virus 420 further, 50 l rescued virus supernatant was injected into incubated 10-d embryonated 421
pathogen-free hen eggs (Charles River, Norwich CT). 48 h post-infection, allantoic fluid 422
containing the virus was removed and stored at -80°C. RMA/S cells (TAP-deficient (42)) were cultured overnight at 27 °C to accumulate peptide 473 receptive K b molecules. Cells were then incubated with peptides at the indicated 474 concentration at room temperature and then shifted to 37 °C for 2 h to denature peptide 475 free K b molecules. Cells were then stained on ice with directly conjugated anti-K b mAb to 476 determine peptide bindings. B8R and OVA (SIINFEKL) peptides bind K b with high affinity, 477
while PB1 binds with intermediate affinity. PA is a D b binding negative control peptide. 478
The NSX peptide tested exhibits no significant binding to K b . The experiment was 479 repeated 3 times with highly similar results. 480 481
Supplemental Figure 3 Insertion of eight amino acid peptide into linker sequence 482 of NS1 483
Appending SIINFEKL to the carboxy-terminus of NEG8 results in the insertion of the 484 sequence SFSKLMID (shown in blue) after tyrosine 89 of the linker (amino acids [79] [80] [81] [82] [83] [84] [85] [86] [87] [88] [89] 485 shown in white) between the RNA-binding (red) and effector (light green) domains of NS1. 486
Molecular graphics and analyses were performed with the UCSF Chimera package (43) 487
using PDB file 4OPH, "X-ray structure of full-length H6N6 NS1" retrieved from rcsb.org. 488
Chimera is developed by the Resource for Biocomputing, Visualization, and Informatics 489 at the University of California, San Francisco (supported by NIGMS P41-GM103311). 490 491
Supplemental Figure 4 Construction of NArevSIIN Virus 492
We inserted the sequence indicated (nucleotides in small letters) encoding SIINFEKL in 493 the negative sense of segment 6 RNA resulting in the complementary peptide 494
(QLLEVDDR) inserted into the NA stalk between residues 42 and 43. SIINFEKEL (blue) 495
can be initiated by the Met indicated in green, and a translating ribosome would stop (red 496 dot) after translating 5 additional residues (TSSLN). Upstream of the indicated AUG are 497 6 stop codons prior to the next AUG, making it a very unlikely initiation codon for 498 SIINFEKL translation. 499 500 501 
